Truist Financial’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-43,930
Closed -$1.11M 2545
2022
Q2
$1.11M Sell
43,930
-23,660
-35% -$708K ﹤0.01% 1500
2022
Q1
$2.44M Sell
67,590
-16,791
-20% -$827K ﹤0.01% 1214
2021
Q4
$6.47M Sell
84,381
-3,478
-4% -$307K 0.01% 794
2021
Q3
$8.44M Sell
87,859
-6,873
-7% -$750K 0.01% 695
2021
Q2
$10.1M Buy
94,732
+6,059
+7% +$596K 0.02% 629
2021
Q1
$7.94M Sell
88,673
-2,259
-2% -$249K 0.01% 678
2020
Q4
$9.14M Buy
90,932
+6,020
+7% +$449K 0.02% 626
2020
Q3
$4.15M Buy
84,912
+37,777
+80% +$1.81M 0.01% 793
2020
Q2
$1.93M Buy
+47,135
New +$1.35M ﹤0.01% 1046

Other funds holding CRNC

Truist Financial's CRNC Position: Q3 2022 in Review

Truist Financial sold out of Cerence (CRNC) in Q3 2022, closing a stake of 43,930 shares — an estimated $1.11M sold.

Truist Financial first reported a position in CRNC in Q2 2020 and held it in 9 quarters. The position peaked at $10.1M in Q2 2021. 230 funds tracked by Wall St. Rank hold CRNC as of Q3 2022.

  • Truist Financial reported no remaining Cerence position as of Q3 2022 after selling out during the quarter.
  • Truist Financial sold 43,930 Cerence shares in Q3 2022, an estimated $1.11M.
  • Truist Financial first reported a position in Cerence in Q2 2020 and held it in 9 quarters.
  • Truist Financial's Cerence position peaked at $10.1M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Cerence as of Q3 2022.

Based on Truist Financial's 13F filing for Q3 2022, filed 26 Oct 2022.